Compounding Pharmacy Oversight Under Fire by Senate Committee
The outbreak is tied to injectable epidural steroid medication that was later recalled by NECC. The medication has caused 33 deaths and more than 480 illnesses so far, according to a Senate report.
The Senate Health, Education, Labor and Pensions Committee asked state boards of pharmacy several questions related to compounding pharmacies. The committee also asked the boards to provide their requirements for compounding pharmacies and physicians, as well as any previous complaints or disciplinary actions against NECC in their state, by Dec. 7.
More Articles on the Meningitis Outbreak:"Bureaucratic Inertia" to Blame in NECC's Continued Operation, Senate Committee Says
House Hears Testimony on Meningitis Outbreak
CDC Launches Consultation Services for Clinicians Treating Fungal Meningitis Cases
© Copyright ASC COMMUNICATIONS 2017. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- 5 legislative changes for ASCs leaders to note — Feb. 22, 2017
- Takeda completes Ariad Pharmaceutical acquisition following NY law firm investigation — 3 GI companies making waves
- 19 ASC partnerships for SCA in 2016
- President Trump delays CMS bundles implementation by 60 days: 4 things to know
- GI leader to know: Dr. Shahab Aftahi of Estrella Gastroenterology